Forty-year journey of angiogenesis translational research, Science Translational Medicine, vol.3, pp.114-117, 2011. ,
Integrated approaches to spatiotemporally directing angiogenesis in host and engineered tissues, Acta Biomaterialia, pp.69-111, 2018. ,
Current strategies for the manufacture of small size tissue engineering vascular grafts, Frontiers in Bioengineering and Biotechnology, vol.6, p.41, 2018. ,
Prognostic value of coronary vascular endothelial dysfunction, Circulation, vol.106, pp.653-658, 2002. ,
Endothelial cell metabolism in normal and diseased vasculature, Circulation Research, vol.116, pp.1231-1244, 2015. ,
Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies, Nature Clinical Practice. Cardiovascular Medicine, vol.5, pp.338-349, 2008. ,
Oxidative stress and endothelial dysfunction: clinical evidence and therapeutic implications, Trends in Cardiovascular Medicine, vol.2014, pp.24-165 ,
Type 2 diabetes as an inflammatory cardiovascular disorder, Current Molecular Medicine, vol.5, pp.309-322, 2005. ,
Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction--a novel mechanism for maintaining vascular function, Journal of Hematology and Oncology, vol.7, p.80, 2014. ,
Cellular and molecular biology of aging endothelial cells, Journal of Molecular and Cellular Cardiology, vol.2015, pp.89-122 ,
Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue, Circulation, pp.105-373, 2002. ,
Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease, Journal of the American College of Cardiology, vol.46, pp.827-834, 2005. ,
Overcoming disease-induced growth factor resistance in therapeutic angiogenesis using recombinant co-receptors delivered by a liposomal system, Biomaterials, vol.2014, pp.35-196 ,
Insulin downregulates the transcriptional coregulator CITED2, an inhibitor of proangiogenic function in endothelial cells, Diabetes, vol.65, pp.3680-3690, 2016. ,
Ceramideactivated phosphatase mediates fatty acid-induced endothelial VEGF resistance and impaired angiogenesis, American Journal of Pathology, vol.184, pp.1562-1576, 2014. ,
Modulation of VEGF receptor 2 signaling by protein phosphatases, Pharmacological Research, vol.2017, pp.115-107 ,
Clements RT & Sellke FW. Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes, Circulation, pp.116-147, 2007. ,
Metabolic regulation of angiogenesis in diabetes and aging, Physiology, vol.32, pp.290-307, 2017. ,
Implementing genome-driven oncology, Cell, vol.2017, pp.168-584 ,
Synergistic effect of angiopoietin-1 and vascular endothelial growth factor on neoangiogenesis in hypercholesterolemic rabbit model with acute hindlimb ischemia, Life Sciences, issue.03, pp.318-325, 2003. ,
Enhanced angiogenesis and improvement of neuropathy by cotransfection of human hepatocyte growth factor and prostacyclin synthase gene, FASEB Journal, pp.17-779, 2003. ,
Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hindlimb post-ischaemic recovery in mice, Diabetologia, vol.47, pp.1055-1063, 2004. ,
Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats, Diabetes, vol.59, pp.51-60, 2010. ,
VEGF and IGF delivered from alginate hydrogels promote stable perfusion recovery in ischemic hind limbs of aged mice and young rabbits, Journal of Vascular Research, vol.54, pp.288-298, 2017. ,
Therapeutic angiogenesis in diabetes and hypercholesterolemia: influence of oxidative stress. Antioxidants and Redox Signaling, 1945. ,
Patterns of diffusion through skin capillaries in patients with longterm diabetes, New England Journal of Medicine, vol.1982, pp.307-1305 ,
Diabetes causes bone marrow endothelial barrier dysfunction by activation of the RhoA-Rho-associated kinase signaling pathway. Arteriosclerosis, Thrombosis, and Vascular Biology, pp.33-555, 2013. ,
Therapeutic angiogenesis in cardiovascular disease, Nature Reviews. Drug Discovery, vol.2, pp.863-871, 2003. ,
Angiogenic gene therapy in cardiovascular diseases: dream or vision?, European Heart Journal, vol.38, pp.1365-1371, 2017. ,
Growing better blood vessels, Nature Biotechnology, pp.19-1019, 2001. ,
Growth factor-induced therapeutic angiogenesis in the heart: protein therapy, Cardiovascular Research, pp.65-649, 2005. ,
Growth factor-induced therapeutic angiogenesis and arteriogenesis in the heart--gene therapy, Cardiovascular Research, pp.65-656, 2005. ,
Current status of cardiovascular gene therapy, Molecular Therapy, vol.15, pp.1233-1247, 2007. ,
VEGF gene delivery to myocardium: deleterious effects of unregulated expression, Circulation, vol.102, pp.898-901, 2000. ,
Regenerative medicine: current therapies and future directions, PNAS, vol.2015, pp.112-14452 ,
Therapeutic angiogenesis due to balanced single-vector delivery of VEGF and PDGF-BB, FASEB Journal, vol.2012, pp.26-2486 ,
Long-term safety and stability of angiogenesis induced by balanced single-vector co-expression of PDGF-BB and VEGF164 in skeletal muscle, Scientific Reports, 20166. ,
Polymeric system for dual growth factor delivery, Nature Biotechnology, pp.19-1029, 2001. ,
Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2, Nature Medicine, pp.9-604, 2003. ,
Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure, Circulation, vol.124, pp.1059-1069, 2011. ,
Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs, vol.104, pp.12140-12145, 2007. ,
IRES-based vector coexpressing FGF2 and Cyr61 provides synergistic and safe therapeutics of lower limb ischemia, Molecular Therapy, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00419435
Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD), American Heart Journal, pp.161-581, 2011. ,
Endothelial progenitor cells: precursors for angiogenesis, Seminars in Thoracic and Cardiovascular Surgery, vol.15, pp.250-258, 2003. ,
Angiogenic cell-based therapy for the treatment of ischemic cardiovascular diseases, Thrombosis Research, p.130, 2012. ,
Extracellular vesicles in coronary artery disease, Nature Reviews. Cardiology, vol.14, pp.259-272, 2017. ,
Potential role of exosomes in mending a broken heart: nanoshuttles propelling future clinical therapeutics forward. Stem Cells International, 2017. ,
Regulation of microvascularization in heart failure -an endothelial cell, noncoding RNAs and exosome liaison. Non-Coding RNA Research, vol.2, pp.45-55, 2017. ,
Extracellular vesicles in diagnostics and therapy of the ischaemic heart: position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology, Cardiovascular Research, pp.114-133, 2018. ,
MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy, Journal of Clinical Investigation, vol.123, pp.2143-2154, 2013. ,
Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction, Cardiovascular Research, pp.103-530, 2014. ,
Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction, European Heart Journal, vol.2017, pp.38-201 ,
Therapeutic applications of polymeric artificial cells, Nature Reviews Drug Discovery, vol.4, pp.221-235, 2005. ,
Lymphangiogenesis in development and human disease, Nature, vol.438, pp.946-953, 2005. ,
Selective stimulation of cardiac lymphangiogenesis reduces myocardial edema and fibrosis leading to improved cardiac function following myocardial infarction, Circulation, vol.2016, pp.133-1484 ,
URL : https://hal.archives-ouvertes.fr/inserm-02296561
Apelin modulates pathological remodeling of lymphatic endothelium after myocardial infarction, JCI Insight, 20172. ,
Cardiac lymphatics in health and disease, Nature Reviews Cardiology, vol.2019, pp.16-56 ,
Adenoviral intramyocardial VEGF-D?N?C gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I/IIa study with 1-year follow-up, European Heart Journal, vol.38, pp.2547-2555, 2017. ,
Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle, Circulation Research, vol.104, pp.1302-1312, 2009. ,
Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization ,
, , 2573.
/HGF induce Prox-1 expression in the chick embryo chorioallantoic membrane lymphatic vasculature, Clinical and Experimental Medicine, vol.10, pp.169-172, 2010. ,